January 9, 2012

Endo Pharmaceuticals announced a short-term supply constraint of analgesic products, including Opana ER, due to the temporary shutdown of a manufacturing facility operated by Novartis Consumer Health.

May 5, 2011

A generic drug maker has launched its version of a pain medication made by Endo Pharmaceuticals.